Evidence suggests that adoption of oncology biosimilars in Medicare value-based payment models has produced substantial cost ...
The Draft Guidelines emphasise how mergers can increase EU firms’ scale, competitiveness, and resilience, but also expand the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results